Xia Wang Weiwei Peng Zhimin Zeng Jing Cai Anwen Liu
10.3389/fonc.2021.720819
Front Oncol
2021 Dec 22;11:720819.
egfr fusion vopp1 icotinib lung adenocarcinoma osimertinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/35004270/
Case Reports
PMC8727519
35004270
Emerging a Novel VOPP1-EGFR Fusion Coexistent With T790M as an Acquired Resistance Mechanism to Prior Icotinib and Sensitive to Osimertinib in a Patient With EGFR L858R Lung Adenocarcinoma: A Case Report
2021